(FIGS) Figs - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30260D1037
FIGS: Healthcare Apparel, Scrubwear, Outerwear, Footwear, Accessories
FIGS, Inc. (NYSE:FIGS) is a direct-to-consumer healthcare apparel and lifestyle company that has modernized the way healthcare professionals think about their workwear. Founded in 2013 and headquartered in Santa Monica, California, the company has carved out a niche by offering high-quality, fashion-forward scrubwear and non-scrubwear products designed specifically for medical professionals. Their product lineup includes outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and a range of accessories like scrub caps, lanyards, and tote bags. They also cater to a broader lifestyle market with offerings such as sports bras, performance leggings, and casual apparel like fleeces and jackets.
The company operates a highly efficient direct-to-consumer digital platform, which includes a website, mobile app, and a growing B2B business. This digital-first approach has allowed FIGS to build strong brand loyalty and gather valuable customer data, which it uses to refine its product offerings and marketing strategies. In addition to its online presence, FIGS has expanded into physical retail with a network of stores, creating a seamless omnichannel shopping experience for its customers.
From a financial perspective, FIGS, Inc. has a market capitalization of approximately $934 million, reflecting its strong growth trajectory since going public. The company currently trades with a trailing P/E ratio of 110.00 and a forward P/E of 64.52, indicating investor confidence in its future earnings potential. With a price-to-book (P/B) ratio of 2.31 and a price-to-sales (P/S) ratio of 1.70, FIGS is positioned as a high-growth company in the healthcare supplies industry. Its focus on recurring revenue through its subscription model and strong customer retention rates makes it an attractive investment for those looking at the intersection of healthcare and consumer discretionary sectors.
FIGS has successfully capitalized on the underserved healthcare apparel market, which has historically been dominated by low-quality, functional but unstylish options. By combining premium materials, modern designs, and a deep understanding of the needs of healthcare professionals, the company has built a loyal customer base. Its ability to scale through its digital platform and expand into new product categories positions it well to continue capturing market share in both the healthcare and broader lifestyle apparel markets.
For investors and fund managers, FIGS represents an opportunity to invest in a company that is modernizing a traditional industry. Its strong brand, customer-centric approach, and data-driven operations make it a standout player in the direct-to-consumer space. The company’s focus on sustainability and community engagement further enhances its appeal, aligning with the growing demand for socially responsible investments.
Additional Sources for FIGS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FIGS Stock Overview
Market Cap in USD | 791m |
Sector | Consumer Cyclical |
Industry | Apparel Manufacturing |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 2021-05-27 |
FIGS Stock Ratings
Growth 5y | -58.2% |
Fundamental | -5.08% |
Dividend | 0.0% |
Rel. Strength Industry | -7.66 |
Analysts | 3.09/5 |
Fair Price Momentum | 3.35 USD |
Fair Price DCF | 9.61 USD |
FIGS Dividends
No Dividends PaidFIGS Growth Ratios
Growth Correlation 3m | -83% |
Growth Correlation 12m | 24.9% |
Growth Correlation 5y | -90.5% |
CAGR 5y | -38.85% |
CAGR/Max DD 5y | -0.43 |
Sharpe Ratio 12m | -1.25 |
Alpha | -11.27 |
Beta | 0.04 |
Volatility | 53.07% |
Current Volume | 1583.3k |
Average Volume 20d | 2220.8k |
As of March 16, 2025, the stock is trading at USD 4.63 with a total of 1,583,338 shares traded.
Over the past week, the price has changed by -3.74%, over one month by -15.82%, over three months by -23.09% and over the past year by -6.84%.
Neither. Based on ValueRay Fundamental Analyses, Figs is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FIGS as of March 2025 is 3.35. This means that FIGS is currently overvalued and has a potential downside of -27.65%.
Figs has received a consensus analysts rating of 3.09. Therefor, it is recommend to hold FIGS.
- Strong Buy: 1
- Buy: 1
- Hold: 7
- Sell: 2
- Strong Sell: 0
According to ValueRays Forecast Model, FIGS Figs will be worth about 3.6 in March 2026. The stock is currently trading at 4.63. This means that the stock has a potential downside of -21.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.3 | 13.6% |
Analysts Target Price | 5.7 | 22.9% |
ValueRay Target Price | 3.6 | -21.8% |